Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (9): 1041-1048.doi: 10.12092/j.issn.1009-2501.2022.09.011

Previous Articles     Next Articles

New Advances in Lipoprotein Lipase

LV Yuan1, WANG Shuzhi2, DAI Bin1, LIANG Zhonghou1   

  1. Hunan Engineering Research Center for Applied Technology of Understory Medicinal Plants, Hunan Polytechnic of Environment and Biology, Hengyang 421005, Hunan, China
  • Received:2022-05-30 Revised:2022-08-02 Online:2022-09-27 Published:2022-10-14

Abstract: Lipoprotein lipase (LPL) is a key enzyme in lipid and lipoprotein metabolism. LPL mainly hydrolyzes triglyceride-rich lipoproteins and provides free fatty acid (FFAs) for metabolic tissues. LPL acts as a molecular bridge between lipoproteins and cell surface lipoprotein receptors, facilitating lipoprotein uptake. Recent studies have shown that LPL is widely expressed in tissues. LPL has a variety of physiological functions, which regulates lipid metabolism and energy balance in the brain. Besides, it is closely related to Alzheimer's disease. This paper mainly reviews the latest research progress of LPL in the nervous system and provides new targets for the treatment and prevention.

Key words: lipoprotein lipase, nervous system, Alzheimer's disease

CLC Number: